ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) - PubMed (original) (raw)

Practice Guideline

. 2013 Oct;34(39):3035-87.

doi: 10.1093/eurheartj/eht108. Epub 2013 Aug 30.

Lars Rydén, Peter J Grant, Stefan D Anker, Christian Berne, Francesco Cosentino, Nicolas Danchin, Christi Deaton, Javier Escaned, Hans-Peter Hammes, Heikki Huikuri, Michel Marre, Nikolaus Marx, Linda Mellbin, Jan Ostergren, Carlo Patrono, Petar Seferovic, Miguel Sousa Uva, Marja-Riita Taskinen, Michal Tendera, Jaakko Tuomilehto, Paul Valensi, Jose Luis Zamorano; ESC Committee for Practice Guidelines (CPG); Jose Luis Zamorano, Stephan Achenbach, Helmut Baumgartner, Jeroen J Bax, Héctor Bueno, Veronica Dean, Christi Deaton, Cetin Erol, Robert Fagard, Roberto Ferrari, David Hasdai, Arno W Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Ales Linhart, Petros Nihoyannopoulos, Massimo F Piepoli, Piotr Ponikowski, Per Anton Sirnes, Juan Luis Tamargo, Michal Tendera, Adam Torbicki, William Wijns, Stephan Windecker; Document Reviewers; Guy De Backer, Per Anton Sirnes, Eduardo Alegria Ezquerra, Angelo Avogaro, Lina Badimon, Elena Baranova, Helmut Baumgartner, John Betteridge, Antonio Ceriello, Robert Fagard, Christian Funck-Brentano, Dietrich C Gulba, David Hasdai, Arno W Hoes, John K Kjekshus, Juhani Knuuti, Philippe Kolh, Eli Lev, Christian Mueller, Ludwig Neyses, Peter M Nilsson, Joep Perk, Piotr Ponikowski, Zeljko Reiner, Naveed Sattar, Volker Schächinger, André Scheen, Henrik Schirmer, Anna Strömberg, Svetlana Sudzhaeva, Juan Luis Tamargo, Margus Viigimaa, Charalambos Vlachopoulos, Robert G Xuereb

Affiliations

• PMID: 23996285
• DOI: 10.1093/eurheartj/eht108

Free article

Practice Guideline

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)

Authors/Task Force Members et al. Eur Heart J. 2013 Oct.

Free article

Erratum in

• Eur Heart J. 2014 Jul 14;35(27):1824

No abstract available

Keywords: Cardiovascular disease; Coronary Interventions; Diabetes mellitus; Diagnostics; Epidemiology; Guidelines; Impaired glucose tolerance; Patient management; Pharmacological treatment; Prevention; Prognosis; Risk factors.

PubMed Disclaimer

Comment in

• Comments on the ESC guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the european society for the study of diabetes.
  Task Force of the SEC for the ESC Guidelines on Diabetes, Prediabetes and Cardiovascular Disease; Expert Reviewers for the ESC Guidelines on Diabetes, Prediabetes And Cardiovascular Disease; Guideliness Committee of the SEC. Task Force of the SEC for the ESC Guidelines on Diabetes, Prediabetes and Cardiovascular Disease, et al. Rev Esp Cardiol (Engl Ed). 2014 Feb;67(2):87-93. doi: 10.1016/j.rec.2013.12.003. Epub 2014 Jan 31. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24795114 No abstract available.

Similar articles

• Comments on the ESC guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the european society for the study of diabetes.
  Task Force of the SEC for the ESC Guidelines on Diabetes, Prediabetes and Cardiovascular Disease; Expert Reviewers for the ESC Guidelines on Diabetes, Prediabetes And Cardiovascular Disease; Guideliness Committee of the SEC. Task Force of the SEC for the ESC Guidelines on Diabetes, Prediabetes and Cardiovascular Disease, et al. Rev Esp Cardiol (Engl Ed). 2014 Feb;67(2):87-93. doi: 10.1016/j.rec.2013.12.003. Epub 2014 Jan 31. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24795114 No abstract available.
• 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps.
  Paneni F. Paneni F. Diab Vasc Dis Res. 2014 Jan;11(1):5-10. doi: 10.1177/1479164113512859. Epub 2013 Nov 19. Diab Vasc Dis Res. 2014. PMID: 24254974 No abstract available.
• ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
  Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD); Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL. Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC), et al. Diab Vasc Dis Res. 2014 May;11(3):133-73. doi: 10.1177/1479164114525548. Diab Vasc Dis Res. 2014. PMID: 24800783 No abstract available.
• 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.
  Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC; ESC Scientific Document Group. Cosentino F, et al. Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486. Eur Heart J. 2020. PMID: 31497854 Review. No abstract available.
• Cardiovascular prevention in patients with diabetes and prediabetes.
  Anselmino M, Gohlke H, Mellbin L, Rydén L. Anselmino M, et al. Herz. 2008 Apr;33(3):170-7. doi: 10.1007/s00059-008-3105-5. Herz. 2008. PMID: 18568310 Review.

Cited by

• Metformin in gestational diabetes: physiological actions and clinical applications.
  Mason T, Alesi S, Fernando M, Vanky E, Teede HJ, Mousa A. Mason T, et al. Nat Rev Endocrinol. 2024 Oct 25. doi: 10.1038/s41574-024-01049-w. Online ahead of print. Nat Rev Endocrinol. 2024. PMID: 39455749 Review.
• Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China.
  Ruan Z, Chen X, Song M, Jia R, Luo H, Ung COL, Hu H. Ruan Z, et al. Diabetes Metab Syndr Obes. 2024 Oct 5;17:3657-3666. doi: 10.2147/DMSO.S483065. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39386037 Free PMC article.
• Cerebrovascular Involvement in Transthyretin Amyloid Cardiomyopathy.
  Haider L, Schrutka L, Tommasino E, Avanzini N, Hauck S, Nowak N, Hengstenberg C, Bonderman D, Thurnher M. Haider L, et al. J Clin Med. 2024 Jul 31;13(15):4474. doi: 10.3390/jcm13154474. J Clin Med. 2024. PMID: 39124740 Free PMC article.
• Effect of diabetes mellitus on 3-year outcomes in patients with acute myocardial infarction with nonobstructive coronary arteries.
  Kim YH, Her AY, Rha SW, Choi CU, Choi BG, Park S, Kang DO, Hyun SJ, Cho JR, Park JY, Park SH, Jeong MH. Kim YH, et al. Cardiol J. 2024;31(5):675-689. doi: 10.5603/cj.97842. Epub 2024 Aug 8. Cardiol J. 2024. PMID: 39115461 Free PMC article.
• PCSK9 Inhibitor: Safe Alternative to Fill the Treatment Gap in Statin-Limited Conditions?
  Xiao Y, Ba Z, Pang S, Liu D, Wang H, Liang H, Wang Y, Yuan J. Xiao Y, et al. Rev Cardiovasc Med. 2022 Nov 9;23(11):380. doi: 10.31083/j.rcm2311380. eCollection 2022 Nov. Rev Cardiovasc Med. 2022. PMID: 39076187 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Bern Open Repository and Information System
  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information